Title
|
|
|
|
The SAATELLITE and EVADE clinical studies within the COMBACTE consortium : a public-private collaborative effort in designing and performing clinical trials for novel antibacterial drugs to prevent nosocomial pneumonia
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia. |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
Clinical infectious diseases. - Chicago, Ill.
| |
Publication
|
|
|
|
Chicago, Ill.
:
2016
| |
ISSN
|
|
|
|
1058-4838
| |
DOI
|
|
|
|
10.1093/CID/CIW245
| |
Volume/pages
|
|
|
|
63
:s:[2]
(2016)
, p. S46-S51
| |
ISI
|
|
|
|
000383202700006
| |
Pubmed ID
|
|
|
|
27481953
| |
Full text (Publisher's DOI)
|
|
|
|
| |
Full text (open access)
|
|
|
|
| |
|